AIM logo

AIM ImmunoTech (AIM) Operating Expenses

Annual Operating Expenses

$32.08 M
+$12.01 M+59.87%

31 December 2023

AIM Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$4.52 M
+$780.00 K+20.88%

30 September 2024

AIM Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AIM Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+59.9%-44.7%
3 y3 years+123.2%+18.7%
5 y5 years+192.2%+48.8%

AIM Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+123.2%-67.9%+45.3%
5 y5 yearsat high+192.2%-67.9%+54.6%
alltimeall timeat high+646.0%-67.9%+477.5%

AIM ImmunoTech Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$4.52 M(+20.9%)
June 2024
-
$3.74 M(-35.2%)
Mar 2024
-
$5.77 M(-59.0%)
Dec 2023
$32.08 M(+59.9%)
$14.06 M(+72.0%)
Sept 2023
-
$8.17 M(+48.5%)
June 2023
-
$5.50 M(+26.7%)
Mar 2023
-
$4.34 M(-22.6%)
Dec 2022
$20.06 M(+22.8%)
$5.61 M(-14.2%)
Sept 2022
-
$6.54 M(+40.5%)
June 2022
-
$4.66 M(+49.8%)
Mar 2022
-
$3.11 M(-43.9%)
Dec 2021
$16.34 M(+13.7%)
$5.54 M(+45.6%)
Sept 2021
-
$3.81 M(+9.9%)
June 2021
-
$3.46 M(-2.1%)
Mar 2021
-
$3.54 M(-27.2%)
Dec 2020
$14.37 M(+23.0%)
$4.86 M(+52.5%)
Sept 2020
-
$3.19 M(+0.2%)
June 2020
-
$3.18 M(+0.4%)
Mar 2020
-
$3.17 M(+8.4%)
Dec 2019
$11.69 M(+6.5%)
$2.92 M(-3.8%)
Sept 2019
-
$3.04 M(-0.1%)
June 2019
-
$3.04 M(+12.7%)
Mar 2019
-
$2.69 M(+2.9%)
Dec 2018
$10.98 M(+2.9%)
$2.62 M(-8.7%)
Sept 2018
-
$2.87 M(-6.7%)
June 2018
-
$3.07 M(+27.1%)
Mar 2018
-
$2.42 M(-5.1%)
Dec 2017
$10.67 M(-16.6%)
$2.55 M(+8.7%)
Sept 2017
-
$2.34 M(-14.0%)
June 2017
-
$2.73 M(-10.8%)
Mar 2017
-
$3.06 M(-20.1%)
Dec 2016
$12.79 M(-15.8%)
$3.82 M(+28.5%)
Sept 2016
-
$2.98 M(+17.2%)
June 2016
-
$2.54 M(-26.4%)
Mar 2016
-
$3.45 M(+37.8%)
Dec 2015
$15.19 M(-15.8%)
$2.50 M(-31.5%)
Sept 2015
-
$3.65 M(-17.7%)
June 2015
-
$4.44 M(-3.2%)
Mar 2015
-
$4.59 M(+7.0%)
Dec 2014
$18.05 M(+12.2%)
$4.29 M(+5.3%)
Sept 2014
-
$4.07 M(-15.7%)
June 2014
-
$4.83 M(-0.8%)
Mar 2014
-
$4.87 M(+47.8%)
Dec 2013
$16.08 M(-13.4%)
$3.29 M(-22.4%)
Sept 2013
-
$4.24 M(+2.6%)
June 2013
-
$4.13 M(-6.3%)
Mar 2013
-
$4.41 M(-41.4%)
Dec 2012
$18.56 M(+38.4%)
$7.54 M(+87.6%)
Sept 2012
-
$4.02 M(+15.6%)
June 2012
-
$3.47 M(-1.8%)
Mar 2012
-
$3.54 M(+0.9%)
Dec 2011
$13.41 M(-11.6%)
$3.51 M(+3.7%)
Sept 2011
-
$3.38 M(+9.9%)
June 2011
-
$3.08 M(-10.4%)
Mar 2011
-
$3.44 M(-17.9%)
Dec 2010
$15.18 M
$4.19 M(+18.1%)
Sept 2010
-
$3.55 M(+1.8%)
June 2010
-
$3.48 M(-12.2%)
DateAnnualQuarterly
Mar 2010
-
$3.96 M(+3.0%)
Dec 2009
$12.79 M(+4.2%)
$3.85 M(+64.7%)
Sept 2009
-
$2.34 M(-39.2%)
June 2009
-
$3.84 M(+39.2%)
Mar 2009
-
$2.76 M(-3.3%)
Dec 2008
$12.28 M(-36.8%)
$2.85 M(-12.7%)
Sept 2008
-
$3.27 M(+10.8%)
June 2008
-
$2.95 M(-7.9%)
Mar 2008
-
$3.20 M(-22.5%)
Dec 2007
$19.42 M(+5.8%)
$4.13 M(-33.8%)
Sept 2007
-
$6.25 M(+53.2%)
June 2007
-
$4.08 M(-17.8%)
Mar 2007
-
$4.96 M(+13.5%)
Dec 2006
$18.35 M(+73.0%)
$4.37 M(+15.3%)
Sept 2006
-
$3.79 M(-19.0%)
June 2006
-
$4.67 M(-15.4%)
Mar 2006
-
$5.52 M(+69.4%)
Dec 2005
$10.61 M(+6.0%)
$3.26 M(+37.5%)
Sept 2005
-
$2.37 M(-11.6%)
June 2005
-
$2.68 M(+16.8%)
Mar 2005
-
$2.29 M(+10.3%)
Dec 2004
$10.01 M(+35.1%)
$2.08 M(-8.4%)
Sept 2004
-
$2.27 M(+23.9%)
June 2004
-
$1.83 M(-51.8%)
Mar 2004
-
$3.81 M(+66.8%)
Dec 2003
$7.41 M(+6.4%)
$2.28 M(+20.7%)
Sept 2003
-
$1.89 M(+11.7%)
June 2003
-
$1.69 M(+9.9%)
Mar 2003
-
$1.54 M(+96.9%)
Dec 2002
$6.96 M(-24.3%)
$782.00 K(-60.1%)
Sept 2002
-
$1.96 M(-6.5%)
June 2002
-
$2.10 M(-1.1%)
Mar 2002
-
$2.12 M(+21.2%)
Dec 2001
$9.19 M(-10.9%)
$1.75 M(-22.6%)
Sept 2001
-
$2.26 M(-9.7%)
June 2001
-
$2.50 M(-6.4%)
Mar 2001
-
$2.68 M(-5.7%)
Dec 2000
$10.32 M(-25.1%)
$2.84 M(+11.7%)
Sept 2000
-
$2.54 M(+1.2%)
June 2000
-
$2.51 M(+6.3%)
Mar 2000
-
$2.36 M(-56.9%)
Dec 1999
$13.78 M(+74.4%)
$5.48 M(+138.1%)
Sept 1999
-
$2.30 M(-20.7%)
June 1999
-
$2.90 M(-9.4%)
Mar 1999
-
$3.20 M(+39.1%)
Dec 1998
$7.90 M(+14.5%)
$2.30 M(+15.0%)
Sept 1998
-
$2.00 M(+11.1%)
June 1998
-
$1.80 M(0.0%)
Mar 1998
-
$1.80 M(+5.9%)
Dec 1997
$6.90 M(+38.0%)
$1.70 M(+6.3%)
Sept 1997
-
$1.60 M(+23.1%)
June 1997
-
$1.30 M(-48.0%)
Mar 1997
-
$2.50 M(+78.6%)
Dec 1996
$5.00 M(+16.3%)
$1.40 M(-17.6%)
Sept 1996
-
$1.70 M(+54.5%)
June 1996
-
$1.10 M(+37.5%)
Mar 1996
-
$800.00 K
Dec 1995
$4.30 M
-

FAQ

  • What is AIM ImmunoTech annual total operating expenses?
  • What is the all time high annual operating expenses for AIM ImmunoTech?
  • What is AIM ImmunoTech annual operating expenses year-on-year change?
  • What is AIM ImmunoTech quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly operating expenses year-on-year change?

What is AIM ImmunoTech annual total operating expenses?

The current annual operating expenses of AIM is $32.08 M

What is the all time high annual operating expenses for AIM ImmunoTech?

AIM ImmunoTech all-time high annual total operating expenses is $32.08 M

What is AIM ImmunoTech annual operating expenses year-on-year change?

Over the past year, AIM annual total operating expenses has changed by +$12.01 M (+59.87%)

What is AIM ImmunoTech quarterly total operating expenses?

The current quarterly operating expenses of AIM is $4.52 M

What is the all time high quarterly operating expenses for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly total operating expenses is $14.06 M

What is AIM ImmunoTech quarterly operating expenses year-on-year change?

Over the past year, AIM quarterly total operating expenses has changed by -$3.66 M (-44.74%)